April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Visual and IOP Outcomes After PRK in Pigment Dispersion Syndrome
A. Hammer; K. Bower; D. Sediq; J. Edwards; K. Wroblewski; C. Kuzmowych; J. Eaddy; C. Coe
Author Affiliations & Notes
  • A. Hammer
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • K. Bower
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • D. Sediq
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • J. Edwards
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • K. Wroblewski
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • C. Kuzmowych
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • J. Eaddy
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • C. Coe
    Ophthalmology, Walter Reed Army Medical Center, Washington, Dist. of Columbia
  • Footnotes
    Commercial Relationships  A. Hammer, None; K. Bower, None; D. Sediq, None; J. Edwards, None; K. Wroblewski, None; C. Kuzmowych, None; J. Eaddy, None; C. Coe, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 573. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Visual and IOP Outcomes After PRK in Pigment Dispersion Syndrome
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      A. Hammer, K. Bower, D. Sediq, J. Edwards, K. Wroblewski, C. Kuzmowych, J. Eaddy, C. Coe; Visual and IOP Outcomes After PRK in Pigment Dispersion Syndrome. Invest. Ophthalmol. Vis. Sci. 2009;50(13):573.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To evaluate safety and efficacy of PRK in patients with pigment dispersion syndrome (PDS).

Methods: : We reviewed pre- and 1M, 3M, 6M, and 12M post-op records of patients with PDS who underwent PRK between January 2002 and July 2008. Data for analysis included gender, age, ablation depth (AD), surgical complications, manifest spherical equivalent (MSE), uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), intraocular pressure (IOP), central corneal thickness (CCT), cup-to-disc (C/D) ratio, and post-op complications. Pre- and post-op results were compared using a paired T-test and p < 0.05 was considered statistically significant.

Results: : 19 eyes of 10 soldiers (9 males and 1 female) mean age 40.6+/-8.1 years (range 25 to 56 years) with at least 6 months follow-up were included for the review. Mean MSE pre-op was -3.00+/-2.26D (range -1.25 to -7.63D). Mean AD was 47.7+/-26.6 µ (range 17.3 to 113.6 µ). At the final follow-up, mean 342.2 days post-op (range 186 to 1001 days), UCVA was 20/15 or better in 63.2%, 20/20 or better in 84.2%, 20/25 or better in 89.8%, and 20/30 or better in 100% of eyes. Post-op 89.5% of eyes were within 0.5D and 100% within 1.00D of emmetropia. BSCVA was unchanged from pre-op in 78.9% of eyes, while 21.1% of eyes gained one line BSCVA. No eye lost BSCVA from any cause. Post-op IOP (uncorrected) was lower than baseline (17.2+/-3.4 mmHg) at 1M (15.3+/-4.3 mmHg, p=0.006), 3M (15.3+/-4.8 mmHg, p=0.213), 6M (14.7+/-3.9 mmHg, p=0.001), and final (14.3+/-3.7 mmHg, p=0.001). However, when corrected for change in CCT and curvature [IOP = (GAT + 0.025*AD + 0.34*MSE), Rosa et al, 1998] mean post-op IOP was unchanged from baseline at 1M (17.4+/-4.5 mmHg, p=0.77), 3M (17.6+/-4.2 mmHg, p=0.56), 6M (16.9+/-4.1 mmHg, p=0.68), and final (16.5+/-3.4 mmHg, p=0.27). Three of 10 patients (30%) were steroid responders, managed with a single topical agent which was discontinued after completing steroids. There was no significant change in mean C/D ratio from baseline (0.368+/-0.113) to final visit (0.376+/-0.128, p=0.203).

Keywords: refractive surgery: PRK 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept